Candriam Equities L Oncology Impact R-H/ LU1864483083 /
| NAV06/06/2024 | Chg.+0.6500 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 194.0700EUR | +0.34% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | - | - | - | - | - | - | - | - | - | - | 3.80 | - |
| 2022 | -10.61 | -1.92 | 4.33 | -6.01 | -1.54 | -0.31 | 4.18 | -3.41 | -5.17 | 6.64 | 5.71 | -3.82 | -12.68% |
| 2023 | 1.90 | -4.09 | 1.15 | 2.65 | -2.80 | -0.13 | 0.71 | -2.23 | -5.41 | -6.53 | 8.95 | 5.51 | -1.42% |
| 2024 | 1.23 | 3.97 | 1.35 | -3.54 | 2.29 | 2.48 | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 10.71% | 10.95% | 11.66% | -% | -% |
| Ratio de Sharpe | 1.45 | 2.17 | 0.15 | - | - |
| Le meilleur mois | +5.51% | +5.51% | +8.95% | +8.95% | - |
| Le plus défavorable mois | -3.54% | -3.54% | -6.53% | -10.61% | - |
| Perte maximale | -6.97% | -6.97% | -16.11% | - | - |
| Surperformance | - | - | - | - | - |
Toutes les cotations dans EUR
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,402.3501 | +8.18% | +4.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,567.2300 | +8.32% | +5.38% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.7400 | +4.62% | -5.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,235.0200 | +4.75% | +15.35% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.9800 | +7.83% | +3.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.2300 | +4.97% | +13.24% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2600 | +6.82% | +1.10% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3900 | +7.73% | +3.67% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,691.0000 | +2.80% | +0.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.1100 | +4.63% | +14.96% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,113.1299 | +5.61% | -3.17% | |
| Candriam Equities L Oncology Imp... | reinvestment | 259.9500 | +5.87% | +16.14% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.1800 | +4.19% | -6.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.9900 | +7.72% | +3.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.0700 | +5.49% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,843.8000 | +5.09% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,875.2300 | +7.38% | +3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.6200 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 273.5400 | +6.37% | +0.73% |
Performance
| CAD | +7.85% | ||
|---|---|---|---|
| 6 Mois | +12.90% | ||
| 1 An | +5.49% | ||
| 3 Ans | - | ||
| 5 Ans | - | ||
| 10 ans | - | ||
| Depuis le début | -5.78% | ||
| Année | |||
| 2023 | -1.42% | ||
| 2022 | -12.68% | ||
